Qube Research & Technologies LTD Opko Health, Inc. Transaction History

Qube Research & Technologies LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	SELL	$1.23 - $1.63 $1,071 - $1,419	-871 Reduced 1.16%	74,259 $112,000
Q3 2023 Nov 13, 2023	BUY	$1.5 - $2.17 $112,695 - $163,032	75,130 New	75,130 $120,000
Q4 2022 Feb 14, 2023	BUY	$1.05 - $2.01 $189,466 - $362,692	180,444 Added 598.03%	210,617 $263,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.81 $54,613 - $84,786	30,173 New	30,173 $57,000
Q1 2021 May 14, 2021	SELL	$4.19 - $5.99 $114,546 - $163,754	-27,338 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.27 - $4.87 $14,240 - $21,208	4,355 Added 18.95%	27,338 $108,000
Q3 2020 Nov 12, 2020	BUY	$2.99 - $5.96 $33,819 - $67,413	11,311 Added 96.91%	22,983 $85,000
Q2 2020 Aug 14, 2020	BUY	$1.15 - $3.41 $13,422 - $39,801	11,672 New	11,672 $40,000

255

187M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.27B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.